Elixir sulfanilamide
A historical pharmaceutical disaster
Elixir Sulfanilamide was a pharmaceutical preparation that caused a significant public health disaster in the United States in 1937. The incident led to the deaths of over 100 people and prompted the passage of the 1938 Federal Food, Drug, and Cosmetic Act.
Background
Sulfanilamide was one of the first antibiotics used to treat bacterial infections. It was effective against a wide range of infections and was widely used in the 1930s. However, the compound was not very soluble in water, which made it difficult to formulate as a liquid medication.
Development of Elixir Sulfanilamide
In 1937, the S.E. Massengill Company, a pharmaceutical manufacturer, developed a liquid form of sulfanilamide by dissolving it in diethylene glycol, a chemical commonly used as an industrial solvent and antifreeze. The resulting product was marketed as "Elixir Sulfanilamide."
Toxicity and Public Health Impact
Diethylene glycol is highly toxic to humans, and its ingestion can lead to renal failure, neurological damage, and death. The use of diethylene glycol in Elixir Sulfanilamide was not tested for safety, and the product was released to the market without adequate safety evaluations.
The consumption of Elixir Sulfanilamide led to mass poisoning, with over 100 reported deaths, including many children. The symptoms of poisoning included severe abdominal pain, vomiting, convulsions, and kidney failure.
Regulatory Response
The Elixir Sulfanilamide disaster highlighted the need for stricter regulations on drug safety. In response to the tragedy, the United States Congress passed the Federal Food, Drug, and Cosmetic Act of 1938. This legislation required that drugs be tested for safety before being marketed and gave the Food and Drug Administration (FDA) the authority to oversee drug safety.
Legacy
The Elixir Sulfanilamide incident is often cited as a pivotal moment in the history of drug regulation. It underscored the importance of rigorous safety testing and the need for regulatory oversight to protect public health. The tragedy also raised public awareness about the potential dangers of untested pharmaceuticals.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD